Neuro-Optometry

NeurOPrism (™) Institute-Division of Gottlieb Vision Group (PC)

​

​

Dr. Danny Gottlieb, of the NeurOPrism (™) Institute has developed a patented prism therapy for Averted Gaze. The Averted Gaze Prism(™) allows individuals with autism of all ages, to hold fixation and learn again to read and function in activities of daily life. The Prism makes possible improvements with practice, and subsequent neuro-rehabilitation therapies. 

​

Successes

​

NeurOPrism Institute has proven the effectiveness of the patented Visual Field Awareness System (VFAS) (™) for hemianopia, in acquired brain injury, and stroke. Also recently NeurOPrism Institute founder Dr. D. Gottlieb patented the revolutionary Visual Field Expansion System (VFES)(™), a breakthrough providing a prism therapy for spatial neglect. His patented Averted Gaze Prism also shows tremendous promise for breaking through the new frontiers. Research has focused on other conditions including vision loss from COVID-19, and epilepsy, migraines, etc.

​

These therapies accelerate neuroplasticity, and individuals held back by their  visual deficits are immediately able to see a potential for improvement. Even when wearing the diagnostic lenses clients often want to take them home so they can continue to practice learning to see and function immediately. They don’t even want to wait for a prescription, they see immediate potential for improvement!